Advertisement

Topics

ForTe BV Company Profile

19:21 EST 9th December 2018 | BioPortfolio

ForTe bv is a subsidiary of the ForTe IQ group of companies based in The Netherlands involved in the development and licensing of pharmaceutical application forms and technologies. The company was founded in February 2000 and has over 25 years of combined specialist
experience in product & formulation technology development for the pharmaceutical, cosmeceutical and food industries. Our team takes pride in a respectable and successful track record of current activities.
ForTe bv focuses on controlled release, instant suspension and taste masking technologies. It is capable of handling and coordinating projects from formulation design to EU MRP.
Specialised in the design, implementation and assessment of several application technologies and manufacturing techniques, we provide a range of “turn-key” projectmanagement and
consultancy services for national and international clients.

Location

Lindenlaan 31c
AC MOLENHOEK (LB)
NL 6584
Netherlands

Contact

Phone: 31 (0)24 6754004
Fax: 31 (0)24 6754005
Email: info@forte-bv.nl


News Articles [16 Associated News Articles listed on BioPortfolio]

All-New 2019 Kia Forte Soars In Heart-Pounding Marketing Campaign

IRVINE, Calif., Sept. 19, 2018 /PRNewswire/ -- Stung with styling cues from the award-winning Stinger, the all-new 2019 Kia Forte is now arriving in showrooms Read more...

Updated data from the FORTE trial of carfilzomib plus lenalidomide or cyclophosphamide for myeloma

Dr Gay speaks with ecancer at EHA 2017 about updated data from the FORTE trial, looking at newly diagnosed myeloma patients treated with carfilzomib plus lenalidomide or cyclophosphamide. She states ...

Novartis: one in the eye

Foresight has not been the Swiss drug manufacturer’s forte

Clementia Appoints Experienced Financial Executive Steve Forte as Chief Financial Officer

MONTREAL, July 13, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical-stage biopharmaceutical company innovating new treatments for people with ultra-rare bone disord...

Forte Earns ISO 9001:2015 and ISO 27001:2013 Certifications

Forte underwent concurrent audits to achieve both certifications within one year, confirming the company’s commitment to delivering secure solutions and quality management systems for its growing cu...

Pending EC decision: Arti-Cell Forte, chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells, Opinion date: 21-Jun-2018

Forte Releases 2018 State of Technology in Clinical Research Report

Forte publishes findings from recent survey on the impact of technology on clinical trial operations. MADISON, Wis. (PRWEB) September 05, 2018 Forte, an industry-leading developer of specialized clin...

News and press releases: First stem cell-based veterinary medicine recommended for marketing authorisation

Arti-Cell Forte is indicated in horses with mild to moderate lameness due to joint inflammation

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Budget Impact Analysis of Oral Fisiogen Ferro Forte versus Intravenous Iron for the Management of Iron Deficiency in Chronic Kidney Disease in Spain.

Iron deficiency is a frequent complication of chronic kidney disease (CKD) that is associated with a decrease in the quality of life of patients and an increase in the risk of other clinical complicat...

Efficient and accurate determination of C T and T relaxation time constants of high-mobility polymers from limited-resolution spectra with optimized pulse sequences and data fitting.

The pulse sequences for the measurement of C T and T relaxation time constants in soft organic solids were modified to include steady-state nuclear Overhauser enhancement with direct polarization (ssN...

Randomized clinical trial to evaluate the efficacy of prostaglandin F to treat purulent vaginal discharge in lactating dairy cows.

The objectives of this study were (1) to assess the effect of purulent vaginal discharge (PVD) on reproductive performance using a 4-point vaginal discharge score (VDS) and (2) to evaluate the effect ...

Clinical Trials [44 Associated Clinical Trials listed on BioPortfolio]

Observational Program Neo-Penotran® Forte

Vaginitis is the most common gynecologic diagnosis in the primary care setting. In approximately 90 percent of affected women, this condition occurs secondary to bacterial vaginosis, vulvo...

Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With EpiDuo Forte Gel

This will be an open-label study designed to assess the safety and plasma PK of topically applied IDP-126 Gel compared to Epiduo Forte Gel.

Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis

The purpose of this study is to assess the efficacy of Neuroskin Forte in relieving the symptoms of dry skin in adults with psoriasis or eczema.

Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been developed in which phospholipid liposomes are delivered to the tear film via the surface of th...

Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been developed in which phospholipid liposomes are delivered to the tear film via the surface of th...

Companies [12 Associated Companies listed on BioPortfolio]

Forte, LLC

Forte is the industry leader in probate data and solutions that increase probate recoveries. Forte helps organizations maximize recoveries on probate accounts while protecting their reputation and rel...

ForTe BV

ForTe bv is a subsidiary of the ForTe IQ group of companies based in The Netherlands involved in the development and licensing of pharmaceutical application forms and technologies. The company was fou...

FORTE DESIGN SYSTEMS

As electronic companies strive to meet market demands, they face new challenges in managing the complexity of electronic device design against shrinking project schedules. Forte Design Systems offers ...

Kia Motors America

Kia Motors America offers a dynamic and diverse product line to meet the needs of all lifestyles. The vehicle line features the stylish and all-new Forte compact sedan and all-new two-door Forte Koup,...

Forte Holdings, Inc.

More Information about "ForTe BV" on BioPortfolio

We have published hundreds of ForTe BV news stories on BioPortfolio along with dozens of ForTe BV Clinical Trials and PubMed Articles about ForTe BV for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ForTe BV Companies in our database. You can also find out about relevant ForTe BV Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...


Corporate Database Quicklinks



Searches Linking to this Company Record